DE113512C - - Google Patents

Info

Publication number
DE113512C
DE113512C DENDAT113512D DE113512DA DE113512C DE 113512 C DE113512 C DE 113512C DE NDAT113512 D DENDAT113512 D DE NDAT113512D DE 113512D A DE113512D A DE 113512DA DE 113512 C DE113512 C DE 113512C
Authority
DE
Germany
Prior art keywords
compounds
acid
halogen
oxymethyl
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT113512D
Other languages
German (de)
English (en)
Publication of DE113512C publication Critical patent/DE113512C/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DENDAT113512D Active DE113512C (cs)

Publications (1)

Publication Number Publication Date
DE113512C true DE113512C (cs)

Family

ID=383087

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT113512D Active DE113512C (cs)

Country Status (1)

Country Link
DE (1) DE113512C (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012000945A1 (de) 2010-06-30 2012-01-05 Bayer Pharma Aktiengesellschaft Substituierte dicyanopyridine und ihre verwendung

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012000945A1 (de) 2010-06-30 2012-01-05 Bayer Pharma Aktiengesellschaft Substituierte dicyanopyridine und ihre verwendung
DE102010030688A1 (de) 2010-06-30 2012-01-05 Bayer Schering Pharma Aktiengesellschaft Substituierte Dicyanopyridine und ihre Verwendung

Similar Documents

Publication Publication Date Title
DE2705582B2 (cs)
DE113512C (cs)
DE2925943A1 (de) 1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69426021T2 (de) Xamonelin-Tartrat
DE2139516C3 (de) 3,4-Dihydroxybenzylalkoholderivate, deren Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneimittel
DE576604C (de) Verfahren zur Darstellung von Theophyllin und Paraxanthin
DE1568552C3 (de) N-acylierte 1 -Chlorbenzol-24-disulfonamide und Verfahren zu ihrer Herstellung
DE156055C (cs)
DE209728C (cs)
DE189838C (cs)
DE2247828A1 (de) Sulfamoyl-anthranilsaeuren und verfahren zu ihrer herstellung
DE111312C (cs)
DE69035C (de) Verfahren zur Darstellung von p-Aethoxyacetylamidochinolin. (4
DE86562C (cs)
DE1205521B (de) Verfahren zur Herstellung von Guanylhydrazonen
DE213155C (cs)
DE254488C (cs)
AT126160B (de) Verfahren zur Darstellung von Aminoketoalkoholen.
DE96927C (cs)
DE62176C (de) Verfahren zur Darstellung von Zimmtsäure-Guajacolester
DE660237C (de) Verfahren zur Herstellung von Aminen
DE501280C (de) Verfahren zur Darstellung von 4-(B-Oxyaethylamino-) 1-oxybenzol
US757330A (en) Alkoxy-caffein and process of making same.
AT92407B (de) Verfahren zur Darstellung von 1-Allyl-3,7-dimethylxanthin.
DE962885C (de) Verfahren zur Herstellung von Colchiceinsulfoxyden